Pulmonx Announces Appointment Of Mehul Joshi As Chief Financial Officer, Effective April 3, 2024
Portfolio Pulse from Benzinga Newsdesk
Pulmonx Corporation (NASDAQ:LUNG) announced the appointment of Mehul Joshi as Chief Financial Officer, effective April 3, 2024. Joshi, with over 30 years of experience in finance and strategic planning, succeeds John McKune. His background includes roles at Gilead Sciences, ResMed Inc., and PhenomeX Inc., highlighting his capability to lead global finance teams and contribute to Pulmonx's growth strategies.
April 02, 2024 | 8:09 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Pulmonx appoints Mehul Joshi as CFO, effective April 3, 2024. Joshi's extensive experience in finance and strategic planning is expected to support Pulmonx's growth strategies.
The appointment of a CFO with a strong background in finance and strategic planning, especially from reputable companies, is generally viewed positively by the market. Mehul Joshi's experience is likely to be seen as a valuable asset for Pulmonx, potentially leading to positive investor sentiment and a favorable impact on the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100